Home Companies Catalysts Deep Dives

Polycythemia vera

PV · Oncology · 2 drugs · 1 indications

Competitive Landscape (2 drugs)
DrugCompanyMechanismModalityRouteStage
Rusfertide—Hepcidin mimeticPeptideSCPHASE3
JakaviNVSJAK1/2 inhibitorSmall moleculeOralAPPROVED
Indications (1)
Polycythemia vera
Jakavi APPROVEDRusfertide PHASE3
Data from Supabase · Updated 2026-03-24